{"version":"1.0","provider_name":"Leinonen Lithuania","provider_url":"https:\/\/leinonen.eu\/ltu\/lt\/","author_name":"\u017divil\u0117 Mikolaitien\u0117","author_url":"https:\/\/leinonen.eu\/ltu\/lt\/news\/author\/zivile-mikolaitiene\/","title":"Potencial\u016bs poky\u010diai farmacijos teisiniame reglamentavime &#8211; Leinonen Lithuania","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"YP5XDMtPTs\"><a href=\"https:\/\/leinonen.eu\/ltu\/lt\/news\/potencialus-pokyciai-farmacijos-teisiniame-reglamentavime\/\">Potencial\u016bs poky\u010diai farmacijos teisiniame reglamentavime<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/leinonen.eu\/ltu\/lt\/news\/potencialus-pokyciai-farmacijos-teisiniame-reglamentavime\/embed\/#?secret=YP5XDMtPTs\" width=\"600\" height=\"338\" title=\"&#8220;Potencial\u016bs poky\u010diai farmacijos teisiniame reglamentavime&#8221; &#8212; Leinonen Lithuania\" data-secret=\"YP5XDMtPTs\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"Informacijos apie teikiam\u0105 param\u0105 atskleidimas 2019 m. gegu\u017e\u0117s 28 d. Lietuvos Respublikos Seimas pritar\u0117 Sveikatos apsaugos ministerijos pasi\u016blymui d\u0117l Lietuvos Respublikos Farmacijos \u012fstatymo (toliau \u2013 Farmacijos \u012fstatymas) pakeitimo ir papildymo. Si\u016blomi poky\u010diai \u012fpareigot\u0173 vaistini\u0173 preparat\u0173 gamintojus ir j\u0173 atstovus (t. y. platintojus) vie\u0161ai skelbti informacij\u0105 apie teikiam\u0105 tiesiogin\u0119 ar netiesiogin\u0119 param\u0105 sveikatos prie\u017ei\u016bros \u012fstaigoms ir [&hellip;]"}